The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
Work +91 22 2831 3238

Mahua Roy Chowdhury, Managing Partner

Managing Partner Mahua Roy Chowdhury explains how the firm is adapting to clients’ changing needs

What do you see as the main points that differentiate [law firm name] from your competitors?

Our firm represents next generation tech savvy law firms wherein our lawyers are either engineers or scientists.

We design and build our own portfolio management and tracking software based which are an amalgamation of our technical knowledge and wide experience. We provide use of these indigenous systems to our clients as value addition to our service.

Which practices do you see growing in the next 12 months? What are the drivers behind that?

Based on the fact that dynamics of products and market has changed to technology and online respectively, disputes related to ownership of technology, violation of digital licenses and infringements on cyberspace is going to increase.

Further, the bubble created as a result of a fast growing economy is bursting and thus we will witness more frequent triggering of recently introduced Bankruptcy & Insolvency Code.

Another, area of practice will be Infrastructure as the present government has a robust plan and equally fast pace to implement the same.

With the introduction of consolidated tax regime in India, we have been witnessing demand of day to day advise on taxation.

What's the main change you've made in the firm that will benefit clients?

We have expanded our practice areas to provide a one-shop services to our clients. We have accordingly inducted Partners and Associates from practice areas like Corporate, India Entry, Tax, Real Estate and Litigation.

We have opened offices in Delhi and another in Mumbai with complete litigation support.

Further, we now use either a lump-sum or not to exceed fee calculated on the basis of our billable hours as a norm. The exception being only in long-haul contentious disputes, wherein we rely on billable hours. This assist our clients to budget and allocate resources accordingly.

Is technology changing the way you interact with your clients, and the services you can provide them?

We were from the beginning a tech savvy law firm. We are now trying to achieve a paperless office and have successfully implemented the same in our Delhi Office. We provide web based access to our client to review their portfolio and receive additional notifications for deadlines.

Can you give us a practical example of how you have helped a client to add value to their business?

Technology being our forte, we sometime cross-refer our clients and their products. We also update and advise our client to latest introduced technology and how they can integrate the same to augment their reach or improve their products.

Are clients looking for stability and strategic direction from their law firms - where do you see the firm in three years’ time?

We would like to focus and solidify our position in the practice areas introduced by us. We are more interested in providing a holistic services and advisory to our clients.

Legal Developments in India

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

  • Post Marketing Surveillance of Drugs

    Post marketing surveillance is performed after market approval/clinical trials of drugs in India. The regulatory framework for conducting clinical trials of drugs is provided under the Drugs and Cosmetics Act, 1940 (“ Act ”) and the Drugs and Cosmetics Rules, 1945 (“ Rules ”). Further, Part X-A and Schedule Y of the Rules specifically deal with the statutory provisions applicable for clinical trial of drugs in India. Schedule Y divides Clinical trial of drugs into 4 Phases, namely, Human Pharmacology (Phase-I), Therapeutic exploratory trials (Phase-II), Therapeutic confirmatory trials (Phase III) and Post Marketing Trials (Phase-IV).
  • Protection of Biotechnology under Indian Laws

    According to the eighth annual survey conducted by the Association of Biotechnology-Led Enterprises (ABLE) and Bio Spectrum, the Indian biotech industry grew threefold in just five years to report revenues of US$ 3 billion in 2009-10, a rise of 17 per cent over the previous year. Maintaining the momentum of the previous years, the Indian biotech industry grew 16.28 per cent in FY2014; the total industry size was US$ 5 billion at the end of the financial year and it reached US$ 7 billion in FY2015. Fast-paced growth is likely to continue; the industry is expected to increase in size to USD11.6 billion by 2017, driven by a range   of factors such as growing demand, intensive R & D activities and strong government initiatives ( )
  • Cabinet Approves India’s IPR Policy - “Creative India; Innovative India: रचनात्म??

    The Union Cabinet on 13 May 2016 approved the National Intellectual Property Right (IPR) policy roadmap ( ) to foster creativity and innovation, promote entrepreneurship and enhance socio development, enhance access to healthcare, food security and environmental protection. The Policy recognizes the abundance of creative and innovative energies that flow in India, and the need to tap into and channelize these energies towards a better and brighter future for all.
  • Real Estate - India

    Real Estate - India
  • SEBI’s Jurisdiction | Analysis of the Supreme Court judgment in the Sahara case

    The Securities and Exchange Board of India (SEBI) is responsible for investor protection and development and regulation of the securities market in India. The scope of SEBI’s jurisdiction over the issue of securities by public companies is an important issue. This issue was recently considered by the Supreme Court in Sahara India Real Estate Corporation Ltd. and Ors. v. Securities and Exchange Board of India and Anr., MANU/SC/0702/2012; (2012) 8 SCALE 101. This article analyses this judgment and its implications.
  • Mainstreaming the Alternative: Issuance of NCDs

    Debt financing is a significant means for corporates to raise capital. Indian regulators have taken a number of steps to deepen the Indian debt market. Permission has been granted to foreign institutional investors (FIIs) and qualified foreign investors (QFIs) to invest in non-convertible debentures (NCDs) issued by Indian companies. This article summarises the legal and regulatory requirements for Indian companies to issue NCDs to FIIs and QFIs.
  • Options – Not a Part of History Yet

    At the time when India is completing two decades of the economic liberalization there are several laurels which the policymakers can boast of.   The path-breaking shift from the license-raj to a regime focusing on regulation introduced by the Government of India in the landmark year 1991 have been continued through further economic reforms and the same has also found support from the regulators and the market players.
  • Liberalization Back on Track with the Relaxation of Share Transfer Norms

    Soon after the rollback of the much criticized aspect of the Consolidated Foreign Direct Investment policy dated October 1, 2011 which treated foreign investments in Indian securities as external commercial borrowings in case such investments conferred options on the foreign investors, the policy makers have brought more good news for the investor community.
  • Franchising in India

    In the last two decades, India has witnessed a sea change in its foreign investment policy resulting in it being one of the most preferred investment destinations. With growing globalisation and liberalisation, brand awareness has been created in the Indian masses and today India is the one of the biggest and fastest emerging markets for various businesses across the world. Being geographically vast and culturally diverse, India offers the most favorable franchising environment with a huge consumer market. Franchising in this respect has managed to pick up as a successful business module for local companies in India.